NCT06684028 PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
| NCT ID | NCT06684028 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Affiliated Hospital of Jiangnan University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-07-12 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-07-12 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the biological distribution of a new tracer 68Ga-FAPI-JNU in the primary, metastatic and normal tissues of patients with malignant tumors, and to evaluate the biological distribution of 68GA-FAPI-JNU with standardized uptake values.
Eligibility Criteria
Inclusion Criteria: 1. The subjects sign the informed consent voluntarily and can complete the test according to the protocol requirements; 2. Age 18-85 years old, male or female; 3. Clinically diagnosed as malignant tumor, diagnostic criteria refer to biopsy or other imaging such as CT and MRI; 4. ECOG score is 0-3 points; Exclusion Criteria: 1. Patients with a history or allergic constitution to any component of the developer, including alcohol; 2. pregnant or lactating women; 3. Patients with mental illness or related history; 4. Patients who cannot or cannot undergo a PET/CT scan;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06684028 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06684028 currently recruiting?
Yes, NCT06684028 is actively recruiting participants. Contact the research team at ycj_wxd1978@163.com for enrollment information.
Where is the NCT06684028 trial being conducted?
This trial is being conducted at Wuxi, China.
Who is sponsoring the NCT06684028 clinical trial?
NCT06684028 is sponsored by Affiliated Hospital of Jiangnan University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.